Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 
Earnings Analysis: 
RiskMetrics Disappoints, Immucor Rises
Author: 123jump.com Staff
123jump.com
Last Update: 10:23 PM EDT April 07 2008



Email article | Print article

RiskMetrics Group, corporate governance consultant, reported fourth quarter revenue rise of 29% and net income decline of 66%. Earnings fell to $1.2 million or 2 cents per share from $3.7 million or 7 cents a share. For the year 2007, earnings fell to $2.4 million from $16 million a year ago on revenue rise of 19% to $243.6 million. Separately, Immucor third quarter net income increased to $19.3 million from $15 million a year ago.

 
10:00PM New York – RiskMetrics falls after it reported lower than expected earnings.

RiskMetrics Group, Inc. risk-management and corporate-governance services provider said that fourth quarter 2007 revenue increased 28.5% to $67.6 million from $52.6 million in the same period of 2006.

For the quarter ended Dec. 31, the company reported income of $1.2 million, or 2 cents per share, compared with $3.7 million, or 7 cents per share, in the year-ago period.

Full-year 2007 annual revenue increased 19.1% to $243.6 million from $204.5 million in the last year 2006.

For the year, RiskMetrics reported income of $2.4 million, or 4 cents per share, compared with $16 million, or 33 cents per share, in last year 2006.

As of March 31, 2008, the Company anticipates revenue for the fiscal year ending December 31, 2008 to be in the range of $285 million to $295 million. Renewal rates are expected to be between 89% and 91%.

RiskMetrics Group, Inc. (RMG: chart) shares fell 79 cents, or 3.9%, to $19.35.


Immucor, Inc. (BLUD: chart), which supplies equipment to the blood transfusion industry today reported revenue for the fiscal third quarter was $67.0 million, up 17% from $57.1 million in the same period last year.

Net income for the period ended Feb. 29 2008, grew to $19.3 million, or 27 cents per share, from $15 million, or 21 cents per share, in the same period a year 2007.

Immucor, Inc. (BLUD: chart) shares of rose 93 cents, or 3.9%, to $24.53.
More: Earnings Archive

 



 
© 1999-2008 123jump.com. All rights reserved